Gilead’s FOCUS Program Helps Zero In on Early HIV Detection

Описание: In 2010, we established the FOCUS program to enable partners to develop and share best practices in HIV and viral hepatitis screening, diagnosis and linkage to care. Baton Rouge, Louisiana was able to cut the rate of late-stage diagnoses in half.

For more information about Gilead, visit:

Website: https://www.gilead.com
Stories@Gilead: https://stories.gilead.com
Twitter:   / gileadsciences  
LinkedIn:   / gileadsc.  .
Instagram:   / gileadsciences  
Facebook:   / gileadsciences  

About Gilead

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.

The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.